Cold atmospheric plasma decontamination of SARS‐CoV‐2 bioaerosols

Bioaerosols (aerosolized particles with biological origin) are strongly suspected to play a significant role in the transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), especially in closed indoor environments. Thus, control technologies capable of effectively inactivating bioaerosols are urgently needed. In this regard, cold atmospheric pressure plasma (CAP) can represent a suitable option, thanks to its ability to produce reactive species, which can exert antimicrobial action. In this study, results;on the total inactivation of SARS‐CoV‐2 contained in bioaerosols treated using CAP generated in air are reported, demonstrating the possible use of CAP systems for the control of SARS‐CoV‐2 diffusion through bioaerosols. [ FROM AUTHOR] Copyright of Plasma Processes & Polymers is the property of John Wiley & Sons, Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)